主动、以参与者为中心的数字免疫接种后不良事件(AEFI)监测的范围综述:加拿大免疫研究网络研究
本范围综述基于PRISMA-ScR指南,检索2000年1月1日至2021年1月28日文献,纳入27篇出版物,多数来自澳大利亚(n=15)和加拿大(n=6)。研究最多的系统为SmartVax(n=8)、Vaxtracker(n=7)和CANVAS网络(n=6),最常见沟通方式为短信(n=15)和电子邮件(n=14),在线问卷为主要数据收集方法(n=20)。结论认为该领域正被积极研究,作者假设所述方法可作为收集自报主观症状和反应原性的主要方法,补充现有系统,未来需评估。
要点
- 纳入27篇出版物,多数来自澳大利亚(n=15)和加拿大(n=6)。
- 研究最多的系统为SmartVax(n=8)、Vaxtracker(n=7)和CANVAS网络(n=6)。
- 短信(n=15)和电子邮件(n=14)为最常见沟通方式,在线问卷为主要数据收集方法(n=20)。
核心结论
- 主动、以参与者为中心的数字AEFI监测是一个正在被积极研究的领域,如本范围综述所描绘的文献景观所示。
- 作者假设本文描述的AEFI监测方法可能成为从受种者收集自报主观症状和反应原性的主要方法,补充现有系统。
- 未来需要对已识别的数字解决方案进行评估,以改进当前疫苗监测系统,满足当代和未来的公共卫生需求。
研究设计与样本
- 本研究为范围综述,依据PRISMA-ScR指南进行。
- 由医学图书馆员检索OVID-Medline、Embase Classic + Embase和Medrxiv,检索时间为2000年1月1日至2021年1月28日。
- 两名独立评审员根据预先指定的纳入标准确定纳入研究,数据提取使用预先制作的具体变量表格,由一名调查员提取并由第二名核实。
主要发现
- 共27篇出版物符合纳入标准,多数来自澳大利亚(n=15)和加拿大(n=6)。
- 研究最多的主动、以参与者为中心的数字AEFI监测系统为SmartVax(n=8,澳大利亚)、Vaxtracker(n=7,澳大利亚)和加拿大国家疫苗安全(CANVAS)网络(n=6,加拿大)。
- 报告的与受种者沟通的两种最常见方法为短信(n=15)和电子邮件(n=14),在线问卷是主要的数据收集方法(n=20)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Post-licensure adverse events following immunization (AEFI) surveillance is conducted to monitor vaccine safety, such as identifying batch/brand issues and rare reactions, which consequently improves community confidence. The integration of technology has been proposed to improve AEFI surveillance, however, there is an absence of description regarding which digital solutions are successfully being used and their unique characteristics. OBJECTIVES: The objectives of this scoping review were to 1) map the research landscape on digital systems used for active, participant-centred, AEFI surveillance and 2) describe their core components. METHODS: We conducted a scoping review informed by the PRISMA Extension for Scoping Reviews (PRSIMA-ScR) guideline. OVID-Medline, Embase Classic + Embase, and Medrxiv were searched by a medical librarian from January 1, 2000 to January 28th, 2021. Two independent reviewers determined which studies met inclusion based on pre-specified eligibility criteria. Data extraction was conducted using pre-made tables with specific variables by one investigator and verified by a second. RESULTS: Twenty-seven publications met inclusion, the majority of which came from Australia (n = 15) and Canada (n = 6). The most studied active, participant-centred, digital AEFI surveillance systems were SmartVax (n = 8) (Australia), Vaxtracker (n = 7) (Australia), and Canadian National Vaccine Safety (CANVAS) Network (Canada) (n = 6). The two most common methods of communicating with vaccinees reported were short-message-service (SMS) (n = 15) and e-mail (n = 14), with online questionnaires being the primary method of data collection (n = 20). CONCLUSION: Active, participant-centred, digital AEFI surveillance is an area actively being researched as depicted by the literature landscape mapped by this scoping reviewWe hypothesize that the AEFI surveillance approach herein described could become a primary method of collecting self-reported subjective symptoms and reactogenicity from vaccinees, complementing existing systems. Future evaluation of identified digital solutions is necessary to bring about improvements to current vaccine surveillance systems to meet contemporary and future public health needs.
引用
- Psihogios A, Brianne Bota A, Mithani SS, et al. A scoping review of active, participant-centred, digital adverse events following immunization (AEFI) surveillance: A Canadian immunization research network study. Vaccine. 2022. PMID: 35680501. doi:10.1016/j.vaccine.2022.04.103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。